+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Biomaterial Wound Dressing Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5177661
  • Report
  • August 2020
  • Region: Global
  • 110 pages
  • Mordor Intelligence
until Dec 31st 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now


  • 3M Company
  • B. Braun Melsungen AG
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Johnson & Johnson
  • MORE
The Biomaterial Wound Dressing market is driven by advancements in technology, a growing aging population, the rising burden of chronic wounds and problems, and associated with conventional wound healing procedures. Furthermore, an increase in government initiatives, demand for a fast and safe treatment for chronic wounds, an increase in the prevalence of lifestyle disorders such as diabetes leading to venous leg ulcers, pressure ulcers, and diabetic foot ulcers propels the growth of the market. According to the International Diabetes Federation 2019, approximately 463 million adults (20-79 years) were living with diabetes; by 2045 this will rise to 700 million. The proportion of people with type 2 diabetes is increasing in most countries. However, the high cost of treatment and unfavorable reimbursement policies are the few factors that hinder the market growth.

Key Market Trends

Alginate Dressing is Anticipated Have Significant Share in the forecast Period

Alginate dressing refers to the natural wound dressings that are composed of highly absorbent materials and promote healing. These are widely used in exudnent wounds, where there is excess fluid.
  • Alginate dressing is usually made from seed wood thus, highly absorbent and provides a moist wound environment that is favorable in treating dry injuries.
  • Furthermore, alginate dressing is suitable to treat bleeding wounds and keep nerve endings moist reducing pain. This makes them more preferable in treating heavily draining wounds, surgical wounds, first and second-degree burns, and in donor sites, this is likely to fuel the segment growth over the forecast period.
North America Expected to have Significant Market Share in the Forecast Period

North America's biomaterial wound dressing market is projected to have significant market share worldwide. Major factors that are driving the market in the region are rapidly growing aging population, a high number of diabetic population, and the developed healthcare system, which adapts to the novel innovations.​
  • The statistics show that around 30.3 million people in the United States were suffering from diabetes in 2017, and subsequently, the number is increasing. The International Diabetes Federation has stated that in the whole North American region, the number of people suffering from diabetes by the year 2045 may reach up to 62 million.​
  • Moreover, the presence of key market players coupled with their activity in the launching of new products and R&D are expected to bolster the market growth in the region.
Competitive Landscape

The biomaterial wound dressing market is moderately fragmented and competitive. The major market players, such as 3M, Convatec, Mölnlycke Health Care, Smith and Nephew, and B. Braun Melsungen AG, hold a significant market share in the industry. Most of the market players are focusing on bringing advanced products in the market to acquire the maximum market share.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 5


  • 3M Company
  • B. Braun Melsungen AG
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Johnson & Johnson
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
4.2.2 Government Initiatives Regarding Wound Care Treatment
4.3 Market Restraints
4.3.1 Lack of Proper Reimbursement
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Hydrocolloids
5.1.2 Alginate Dressing
5.1.3 Skin Substitutes
5.1.4 Others
5.2 By Application
5.2.1 Wounds
5.2.2 Burns
5.2.3 Ulcers
5.2.4 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 3M Company
6.1.2 ConvaTec Group PLC
6.1.3 DermaRite Industries LLC
6.1.4 B. Braun Melsungen AG
6.1.5 Hollister Incorporated
6.1.6 Integra LifeSciences Holdings Corporation
6.1.7 Johnson & Johnson
6.1.8 Medtronic PLC
6.1.9 Molnlycke Health Care AB
6.1.10 Smith & Nephew PLC

Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • 3M Company
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • B. Braun Melsungen AG
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Molnlycke Health Care AB
  • Smith & Nephew PLC
Note: Product cover images may vary from those shown
5 of 5